Solid Biosciences Inc.
US ˙ NasdaqGS ˙ US83422E2046

Introduction

This page provides a comprehensive analysis of the known insider trading history of David T Howton. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David T Howton has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:SLDB / Solid Biosciences Inc. Chief Operating Officer 24,789
US:SRPT / Sarepta Therapeutics, Inc. EVP, General Counsel 7,708
US:VRTX / Vertex Pharmaceuticals Incorporated SVP & Chief Legal Officer 68,750
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David T Howton. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases SLDB / Solid Biosciences Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SLDB / Solid Biosciences Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SLDB / Solid Biosciences Inc. Insider Trades
Insider Sales SLDB / Solid Biosciences Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SLDB / Solid Biosciences Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-02-14 SLDB Howton David T 5,561 3.9600 5,561 3.9600 22,022 61 2.5200 -8,007 -36.36
2024-12-03 SLDB Howton David T 5,072 5.5986 5,072 5.5986 28,396

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SLDB / Solid Biosciences Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David T Howton as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-02-18 2025-02-14 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -5,561 24,789 -18.32 3.96 -22,022 98,164
2025-02-18 2025-02-13 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 14,687 30,350 93.77
2024-12-04 2024-12-03 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale -5,072 15,663 -24.46 5.60 -28,396 87,691
2024-12-04 2024-12-02 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 13,051 20,735 169.85
2023-12-05 2023-12-04 4 SLDB Solid Biosciences Inc.
Common Stock
S - Sale X -5,367 7,684 -41.12 2.78 -14,920 21,362
2023-12-05 2023-12-02 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 13,051 13,051
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -45,000 7,708 -85.38
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -56,984 0 -100.00
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -1,858 0 -100.00
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -1,280 0 -100.00
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -55,270 31,871 -63.43 171.50 -9,478,805 5,465,876
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -35,757 87,141 -29.09 170.59 -6,099,787 14,865,383
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -8,086 122,898 -6.17 169.56 -1,371,062 20,838,585
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -6,009 130,984 -4.39 168.61 -1,013,177 22,085,212
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 45,000 136,993 48.92 29.03 1,306,350 3,976,907
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 56,984 91,993 162.77 23.85 1,359,068 2,194,033
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 1,858 35,009 5.60 13.71 25,473 479,973
2020-06-22 2020-06-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 1,280 33,151 4.02 13.71 17,549 454,500
2020-02-28 2020-02-28 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
A - Award 37,500 37,500
2020-02-28 2020-02-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 6,700 31,871 26.62
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -59,421 56,984 -51.05
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -18,579 0 -100.00
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -78,000 25,171 -75.60 125.50 -9,789,000 3,158,960
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 59,421 103,171 135.82 23.85 1,417,191 2,460,628
2019-12-17 2019-12-13 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 18,579 43,750 73.81 13.90 258,248 608,125
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -7,900 5,118 -60.69
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -5,590 0 -100.00
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -52 18 -74.29
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -2,440 2,470 -49.69
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -8,580 18,579 -31.59
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -4,025 1,858 -68.42
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -5,685 1,280 -81.62
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -2,804 25,171 -10.02 107.02 -300,084 2,693,800
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 7,900 27,975 39.35 23.85 188,415 667,204
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 5,590 20,075 38.59 13.90 77,701 279,042
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 52 14,485 0.36 13.71 713 198,589
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 2,440 14,433 20.35 13.71 33,452 197,876
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -2,957 11,993 -19.78 105.00 -310,485 1,259,265
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -3,753 14,950 -20.07 105.00 -394,065 1,569,750
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -18,290 18,703 -49.44 105.00 -1,920,450 1,963,815
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 8,580 36,993 30.20 13.90 119,262 514,203
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 4,025 28,413 16.50 13.71 55,183 389,542
2019-11-26 2019-11-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 5,685 24,388 30.40 13.71 77,941 334,359
2019-03-29 2019-03-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -2,362 18,703 -11.21 118.68 -280,322 2,219,672
2019-03-29 2019-03-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 5,319 21,065 33.78
2019-03-04 2019-03-04 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
A - Award 45,000 45,000
2019-03-04 2019-02-28 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
D - Sale to Issuer -3,825 15,746 -19.54
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -16,827 116,405 -12.63 23.85 -401,324 2,776,259
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1,548 5,883 -20.83 13.71 -21,223 80,656
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -3,125 6,965 -30.97 13.71 -42,844 95,490
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -30,000 19,571 -60.52 140.00 -4,200,000 2,739,940
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 16,827 49,571 51.39 23.85 401,324 1,182,268
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 1,548 32,744 4.96 13.71 21,223 448,920
2019-02-01 2019-02-01 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 3,125 31,196 11.13 13.71 42,844 427,697
2018-08-08 2018-08-08 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -6,800 28,071 -19.50 121.02 -822,936 3,397,152
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -37,848 27,159 -58.22 13.90 -526,087 377,510
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -9,056 10,090 -47.30 13.71 -124,158 138,334
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise X -3,096 7,431 -29.41 13.71 -42,446 101,879
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -37,848 34,871 -52.05 136.46 -5,164,738 4,758,497
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 37,848 72,719 108.54 13.90 526,087 1,010,794
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -9,056 34,871 -20.62 136.46 -1,235,782 4,758,497
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 9,056 43,927 25.97 13.71 124,158 602,239
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -3,096 34,871 -8.15 136.46 -422,480 4,758,497
2018-07-17 2018-07-16 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 3,096 37,967 8.88 13.71 42,446 520,528
2018-05-24 2018-05-22 4 SRPT Sarepta Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5,319 0 -100.00
2018-05-24 2018-05-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -1,566 34,871 -4.30 89.22 -139,719 3,111,191
2018-05-24 2018-05-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 5,319 36,437 17.09
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -2,074 13,018 -13.74
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -403 5,590 -6.72
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
M - Exercise -23 70 -24.73
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -609 31,118 -1.92 81.22 -49,463 2,527,404
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 2,074 31,727 6.99 23.85 49,465 756,689
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -68 29,653 -0.23 81.22 -5,523 2,408,417
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 403 29,721 1.37 13.90 5,602 413,122
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -3 29,318 -0.01 81.22 -244 2,381,208
2018-03-16 2018-03-15 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 23 29,321 0.08 13.71 315 401,991
2018-03-07 2018-03-05 4 SRPT Sarepta Therapeutics, Inc.
Stock option (right to buy)
A - Award 70,000 70,000
2017-08-07 2017-08-03 4 SRPT Sarepta Therapeutics, Inc.
Restricted Stock Units
M - Exercise -10,639 0 -100.00
2017-08-07 2017-08-03 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -4,642 29,298 -13.68 37.88 -175,839 1,109,808
2017-08-07 2017-08-03 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 10,639 33,940 45.66
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
M - Exercise -676 15,092 -4.29 23.85 -16,123 359,944
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
M - Exercise -324 93 -77.70 13.71 -4,442 1,275
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 676 23,301 2.99 23.85 16,123 555,729
2017-07-21 2017-07-21 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 324 22,625 1.45 13.71 4,442 310,189
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -5,944 19,146 -23.69 13.71 -81,492 262,492
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -19,056 10,527 -64.42 13.71 -261,258 144,325
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -5,944 22,301 -21.04 41.00 -243,704 914,341
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 5,944 28,245 26.65 13.71 81,492 387,239
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -19,056 22,301 -46.08 41.00 -781,296 914,341
2017-07-21 2017-07-20 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 19,056 41,357 85.45 13.71 261,258 567,004
2017-03-21 2017-03-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -152 22,301 -0.68 30.30 -4,606 675,720
2017-03-14 2017-03-10 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 4,411 4,411
2017-03-14 2017-03-10 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 25,589 25,589
2016-11-10 2016-11-09 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
M - Exercise -1,000 15,768 -5.96
2016-11-10 2016-11-09 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise 1,000 22,453 4.66 23.85 23,850 535,504
2016-09-26 2016-09-22 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -7,000 65,007 -9.72 13.90 -97,300 903,597
2016-09-26 2016-09-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -7,000 21,453 -24.60 60.00 -420,000 1,287,180
2016-09-26 2016-09-22 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 28,453 32.63 13.90 97,300 395,497
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Options (right to buy)
M - Exercise X -8,000 72,007 -10.00 13.90 -111,200 1,000,897
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -1,304 21,453 -5.73 50.00 -65,200 1,072,650
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 19,125 22,757 526.57
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 464 3,632 14.65
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
S - Sale X -8,000 3,168 -71.63 50.00 -400,000 158,400
2016-09-21 2016-09-19 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
M - Exercise X 8,000 11,168 252.53 13.90 111,200 155,235
2016-09-02 2016-08-31 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
F - Taxes -898 3,168 -22.09 26.07 -23,411 82,590
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 25,090 25,090
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 4,910 4,910
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 29,583 29,583
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 417 417
2016-03-02 2016-02-29 4 SRPT Sarepta Therapeutics, Inc.
Common Stock
A - Award 2,762 4,066 211.81
2015-04-22 2015-02-27 4/A SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 80,007 80,007
2015-04-22 2015-02-27 4/A SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 5,993 5,993
2015-03-03 2015-02-27 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 76,397 76,397
2015-03-03 2015-02-27 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 9,603 9,603
2014-03-04 2014-02-28 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award 52,708 52,708
2014-03-04 2014-02-28 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award 2,292 2,292
2013-06-07 2013-06-04 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award -45,000 45,000 -50.00
2013-06-07 2013-06-04 4 SRPT Sarepta Therapeutics, Inc.
Non-Qualified Stock Option (right to buy)
A - Award -42,137 42,137 -50.00
2013-06-07 2013-06-04 4 SRPT Sarepta Therapeutics, Inc.
Incentive Stock Option (right to buy)
A - Award -2,863 2,863 -50.00
2012-11-07 2012-11-05 4 SRPT Sarepta Therapeutics, Inc.
Stock Option (right to buy)
A - Award -150,000 150,000 -50.00
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 68,750 68,750
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,166 19,437 109.65 0.01 102 194
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)